Henry, it looks like your analysis of the Tamoxifen news, was totally correct.
I just got thru listening to the 30 minute CNN special about Breast Cancer and Tamoxifen.
The subject of new, safer drugs, in the pipeline, was mentioned over and over, especially 2nd generation SERMs. They also mentioned Droloxifene, as one of the new SERMs that might be better than Tamoxifen, and without the side effects. The National Cancer Institute spokeswoman said that their next step is to test some of these new drugs.
Overall, the broadcast was favorable towards LGND. I kept saying, "They're talking about LGND", over and over.
Anyone else get the same reaction?
I've got a full position in LGND, at current. I've got to avoid the temptation to get more shares.
Regards, Bob |
